Free Trial

Healthpeak Properties (DOC) Financials

Healthpeak Properties logo
$17.36 +0.52 (+3.09%)
Closing price 05/27/2025 03:59 PM Eastern
Extended Trading
$17.23 -0.13 (-0.74%)
As of 07:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Healthpeak Properties

Annual Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
242 304 498 502 411 44 1,058 413 627 -561
Consolidated Net Income / (Loss)
267 335 516 526 428 60 1,073 423 640 -546
Net Income / (Loss) Continuing Operations
267 335 514 138 161 175 837 423 374 153
Total Pre-Tax Income
273 315 507 128 218 176 839 410 367 136
Total Revenue
2,420 1,981 1,888 1,738 1,427 1,023 930 1,541 1,665 1,461
Net Interest Income / (Expense)
-236 -179 -150 -120 -202 -208 -251 -251 -376 -367
Total Interest Income
45 22 23 38 17 9.84 10 56 89 112
Investment Securities Interest Income
45 22 23 38 17 9.84 10 56 89 112
Total Interest Expense
280 200 173 158 218 218 261 308 464 480
Long-Term Debt Interest Expense
280 200 173 158 218 218 261 308 464 480
Total Non-Interest Income
2,656 2,159 2,038 1,858 1,628 1,230 1,181 1,792 2,040 1,828
Service Charges on Deposit Accounts
568 527 495 471 436 144 144 524 - 525
Other Non-Interest Income
2,087 1,632 1,543 1,387 1,192 1,086 1,037 1,268 2,040 1,303
Total Non-Interest Expense
2,385 1,759 1,716 1,581 1,491 953 892 1,464 1,420 1,347
Other Operating Expenses
1,172 997 994 872 876 498 475 755 842 707
Depreciation Expense
1,057 750 711 684 554 435 405 535 568 505
Impairment Charge
23 -5.60 7.00 23 43 18 11 166 0.00 108
Restructuring Charge
133 18 4.85 1.84 18 1.96 1.14 7.96 9.82 27
Nonoperating Income / (Expense), net
238 93 335 -29 282 107 801 334 122 23
Income Tax Expense
4.35 -9.62 -4.43 -3.26 -9.42 -5.48 -4.40 -1.33 4.47 -9.81
Other Gains / (Losses), net
-1.52 10 1.99 6.10 -67 -6.33 -5.76 11 11 6.59
Net Income / (Loss) Discontinued Operations
0.00 0.00 2.88 388 268 -115 236 - 266 -699
Net Income / (Loss) Attributable to Noncontrolling Interest
25 30 19 21 14 15 12 8.47 12 13
Basic Earnings per Share
$0.36 $0.56 $0.92 $0.93 $0.77 $0.09 $2.25 $0.88 $1.34 ($1.21)
Weighted Average Basic Shares Outstanding
675.68M 547.01M 538.81M 538.93M 530.56M 486.26M 470.55M 468.76M 467.20M 462.80M
Diluted Earnings per Share
$0.36 $0.56 $0.92 $0.93 $0.77 $0.09 $2.24 $0.88 $1.34 ($1.21)
Weighted Average Diluted Shares Outstanding
676.23M 547.28M 539.15M 539.24M 531.06M 489.34M 475.39M 468.94M 467.40M 462.80M
Weighted Average Basic & Diluted Shares Outstanding
699.56M 547.17M 546.78M 539.30M 538.69M 505.41M 470.40M 469.30M 467.60M 463.30M
Cash Dividends to Common per Share
$1.20 $1.20 $1.20 $1.20 $1.48 $1.48 $1.48 $1.48 $2.10 $2.26

Quarterly Income Statements for Healthpeak Properties

This table shows Healthpeak Properties' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 10/31/2024 7/31/2024 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Income / (Loss) Attributable to Common Shareholders
-13 -26 42 4.40 86 146 6.48 71 64 52 118
Consolidated Net Income / (Loss)
-13 -26 50 11 93 153 11 75 69 56 135
Net Income / (Loss) Continuing Operations
-13 -26 50 11 93 153 11 75 69 56 135
Total Pre-Tax Income
-12 -26 54 -3.23 99 155 22 60 67 55 133
Total Operating Income
-30 -43 - - - - - - - - -
Total Gross Profit
144 135 - - - - - - - - -
Total Revenue
173 165 630 627 626 621 546 501 506 496 478
Operating Revenue
173 165 - - - - - - - - -
Total Cost of Revenue
30 30 - - - - - - - - -
Operating Cost of Revenue
30 30 - - - - - - - - -
Total Operating Expenses
173 178 - - - - - - - - -
Selling, General & Admin Expense
34 36 - - - - - - - - -
Marketing Expense
86 88 - - - - - - - - -
Research & Development Expense
53 55 - - - - - - - - -
Total Other Income / (Expense), net
17 17 - - - - - - - - -
Interest & Investment Income
17 18 16 17 14 7.83 5.75 4.98 5.36 5.28 6.16
Other Income / (Expense), net
0.10 -0.26 - - - - - - - - -
Income Tax Expense
0.61 0.65 2.08 -14 1.94 2.73 14 -12 0.79 1.14 0.30
Basic Earnings per Share
($0.06) ($0.13) $0.06 $0.02 $0.12 $0.21 $0.01 $0.13 $0.12 $0.09 $0.22
Weighted Average Basic Shares Outstanding
203.53M 201.87M 699.07M 675.68M 699.35M 702.38M 600.90M 547.01M 547.06M 547.03M 546.84M
Diluted Earnings per Share
($0.06) ($0.13) $0.06 $0.02 $0.12 $0.21 $0.01 $0.13 $0.12 $0.09 $0.22
Weighted Average Diluted Shares Outstanding
203.53M 201.87M 699.12M 676.23M 700.15M 703.27M 601.19M 547.28M 547.33M 547.29M 547.11M
Weighted Average Basic & Diluted Shares Outstanding
204.45M 202.89M 694.73M 699.56M 699.44M 699.29M 703.78M 547.17M 547.07M 547.05M 547.00M

Annual Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
15 42 -93 38 -2.97 45 58 -55 -270 174
Net Cash From Operating Activities
1,070 956 900 795 758 846 849 847 1,214 1,222
Net Cash From Continuing Operating Activities
1,070 956 900 795 758 846 849 847 1,214 1,228
Net Income / (Loss) Continuing Operations
267 335 516 526 428 60 1,073 423 640 -546
Consolidated Net Income / (Loss)
267 335 516 526 428 60 1,073 423 640 -546
Depreciation Expense
1,057 750 711 684 697 660 549 535 573 511
Amortization Expense
-91 -97 -92 -85 -72 11 13 15 20 20
Non-Cash Adjustments to Reconcile Net Income
-208 -114 -354 -356 -404 93 -833 -105 -54 1,296
Changes in Operating Assets and Liabilities, net
45 83 119 26 109 22 46 -20 35 -53
Net Cash From Investing Activities
-114 -577 -876 531 -1,008 -1,449 1,829 1,246 -429 -1,660
Net Cash From Continuing Investing Activities
-114 -577 -876 531 -1,008 -1,449 1,829 1,246 -429 -1,660
Purchase of Property, Leasehold Improvements and Equipment
-116 -114 -109 -111 -94 -109 -106 -115 -91 -84
Purchase of Investment Securities
-592 -855 -1,072 -2,137 -2,441 -2,326 -587 -1,011 -1,246 -2,308
Sale and/or Maturity of Investments
751 371 291 2,742 1,509 514 2,528 2,335 232 628
Other Investing Activities, net
-156 21 13 38 19 382 26 37 28 31
Net Cash From Financing Activities
-941 -337 -117 -1,289 246 647 -2,621 -2,148 -1,054 614
Net Cash From Continuing Financing Activities
-941 -337 -117 -1,289 246 647 -2,621 -2,148 -1,054 614
Issuance of Debt
4,491 11,088 16,382 17,910 5,337 9,905 2,047 1,250 2,794 2,368
Issuance of Common Equity
0.32 0.28 308 5.04 1,069 796 517 28 68 206
Repayment of Debt
-4,358 -10,718 -16,062 -18,448 -5,322 -9,332 -4,401 -2,670 -2,912 -989
Repurchase of Common Equity
-191 -6.52 -68 -13 -11 -5.04 -3.43 -4.79 -8.69 -8.74
Payment of Dividends
-795 -657 -648 -650 -787 -720 -697 -695 -980 -1,047
Other Financing Activities, Net
-90 -45 -29 -93 -41 3.80 -83 -56 -16 85

Quarterly Cash Flow Statements for Healthpeak Properties

This table details how cash moves in and out of Healthpeak Properties' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 10/31/2024 7/31/2024 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Net Change in Cash & Equivalents
126 202 -46 -58 83 2.14 -12 55 -47 43 -9.61
Net Cash From Operating Activities
38 -8.57 279 284 318 316 153 231 253 298 174
Net Cash From Continuing Operating Activities
38 -8.57 279 284 318 316 153 231 253 298 174
Net Income / (Loss) Continuing Operations
-13 -26 50 11 93 153 11 75 69 56 135
Consolidated Net Income / (Loss)
-13 -26 50 11 93 153 11 75 69 56 135
Depreciation Expense
3.47 3.32 269 274 280 283 219 189 185 198 179
Amortization Expense
-3.13 -3.55 -26 -21 -23 -22 -24 -25 -23 -26 -23
Non-Cash Adjustments To Reconcile Net Income
39 39 3.69 29 -61 -125 -52 -22 -5.44 -6.00 -81
Changes in Operating Assets and Liabilities, net
12 -21 -17 -9.50 29 27 -1.75 14 29 76 -36
Net Cash From Investing Activities
91 203 -231 -234 30 188 -98 -216 -222 -195 56
Net Cash From Continuing Investing Activities
91 203 -231 -234 30 188 -98 -216 -222 -195 56
Purchase of Property, Plant & Equipment
-2.44 -2.63 -23 -39 -24 -36 -18 -47 -24 -19 -23
Purchase of Investments
-47 -126 -280 -109 -205 -139 -140 -199 -214 -216 -227
Sale and/or Maturity of Investments
140 332 65 -89 254 354 232 25 6.76 38 303
Net Cash From Financing Activities
-2.33 7.63 -94 -107 -266 -502 -67 40 -77 -60 -240
Net Cash From Continuing Financing Activities
-2.33 7.63 -94 -107 -266 -502 -67 40 -77 -60 -240
Other Financing Activities, net
-2.33 0.96 -10 -9.34 -9.72 -63 -7.25 -6.74 -7.14 -8.20 -23
Cash Income Taxes Paid
0.97 0.52 - - - - - - - - -

Annual Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
19,938 15,699 15,771 15,258 15,920 14,033 12,719 14,088 15,759 21,450
Cash and Due from Banks
120 118 72 158 44 80 111 55 95 340
Restricted Cash
64 51 55 53 67 13 29 27 42 46
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net
15,831 13,028 13,023 12,667 11,120 8,231 10,209 10,732 11,326 11,854
Intangible Assets
817 314 418 520 520 260 305 410 480 587
Other Assets
3,105 2,187 2,203 1,859 3,974 5,448 2,001 2,864 3,009 8,622
Total Liabilities & Shareholders' Equity
19,938 15,699 15,771 15,258 15,920 14,033 12,719 14,088 15,759 21,450
Total Liabilities
10,881 8,774 8,483 8,111 8,573 7,365 6,206 8,494 9,818 11,704
Short-Term Debt
150 720 996 1,166 - 93 91 94 92 94
Other Short-Term Payables
725 657 - - 761 - 392 402 417 431
Long-Term Debt
8,566 6,156 5,502 5,004 6,298 5,909 5,477 7,786 9,097 10,975
Other Long-Term Liabilities
1,439 1,240 1,985 1,941 1,514 1,363 246 211 211 204
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
2.61 49 106 87 57 - - - - -
Total Equity & Noncontrolling Interests
9,055 6,876 7,183 7,059 7,290 6,667 6,513 5,595 5,941 9,746
Total Preferred & Common Equity
8,401 6,350 6,655 6,515 6,734 6,085 5,944 5,301 5,548 9,344
Total Common Equity
8,401 6,350 6,655 6,515 6,734 6,085 5,944 5,301 5,548 9,344
Common Stock
13,547 10,953 10,896 10,639 10,714 9,689 8,876 8,696 8,667 12,113
Accumulated Other Comprehensive Income / (Loss)
29 19 28 -3.15 -3.69 -2.86 -4.71 -24 -30 -30
Other Equity Adjustments
-5,174 -4,622 - - - - -2,927 - - -
Noncontrolling Interest
654 526 528 543 556 582 568 294 394 403

Quarterly Balance Sheets for Healthpeak Properties

This table presents Healthpeak Properties' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 10/31/2024 7/31/2024 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Total Assets
1,693 1,679 19,816 19,938 19,970 20,180 20,542 15,699 15,603 15,604 15,602
Total Current Assets
1,553 1,536 - - - - - - - - -
Cash & Equivalents
924 797 71 120 180 107 102 118 63 104 59
Short-Term Investments
423 512 - - - - - - - - -
Accounts Receivable
129 148 - - - - - - - - -
Prepaid Expenses
26 28 - - - - - - - - -
Other Current Assets
51 50 - - - - - - - - -
Plant, Property, & Equipment, net
0.00 0.00 - - - - - - - - -
Total Noncurrent Assets
140 143 - - - - - - - - -
Goodwill
12 12 - - - - - - - - -
Intangible Assets
9.49 10 748 817 898 1,076 1,160 314 339 364 392
Other Noncurrent Operating Assets
118 121 - - - - - - - - -
Total Liabilities & Shareholders' Equity
1,693 1,679 19,816 19,938 19,970 20,180 20,542 15,699 15,603 15,604 15,602
Total Liabilities
435 445 10,972 10,881 10,748 10,761 10,943 8,774 8,570 8,478 8,379
Total Current Liabilities
410 414 - - - - - - - - -
Accounts Payable
21 13 - - - - - - - - -
Accrued Expenses
14 19 - - - - - - - - -
Customer Deposits
20 22 - - - - - - - - -
Current Deferred Revenue
310 311 - - - - - - - - -
Current Employee Benefit Liabilities
44 49 - - - - - - - - -
Total Noncurrent Liabilities
25 31 - - - - - - - - -
Noncurrent Deferred Revenue
17 21 - - - - - - - - -
Other Noncurrent Operating Liabilities
8.55 9.39 - - - - - - - - -
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,258 1,234 8,829 9,055 9,221 9,417 9,545 6,876 6,984 7,062 7,138
Total Preferred & Common Equity
1,258 1,234 8,188 8,401 8,563 8,757 8,882 6,350 6,457 6,535 6,610
Total Common Equity
1,258 1,234 8,188 8,401 8,563 8,757 8,882 6,350 6,457 6,535 6,610
Common Stock
2,319 2,283 13,526 13,547 13,544 13,560 13,623 10,953 10,949 10,932 10,907
Retained Earnings
-1,062 -1,049 -5,345 - - - -4,780 - - - -
Accumulated Other Comprehensive Income / (Loss)
0.38 -0.02 6.93 29 -12 42 39 19 37 31 19

Annual Metrics And Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
22.18% 4.90% 8.63% 21.85% 39.48% 9.97% -39.63% -7.46% 13.96% 22.04%
EBITDA Growth
14.53% 10.63% 4.50% 34.86% -24.25% 23.41% -4.12% -25.31% 29.98% -12.90%
EBIT Growth
-84.15% 29.04% 9.18% 344.16% -192.51% 83.56% -50.44% -68.74% 115.46% -56.59%
NOPAT Growth
-84.87% 31.83% 7.41% 339.98% -193.61% 88.28% -50.34% -68.25% 98.55% -53.55%
Net Income Growth
-20.15% -35.18% -1.81% 22.81% 613.03% -94.41% 154.00% -33.96% 217.11% -158.34%
EPS Growth
-35.71% -39.13% -1.08% 20.78% 755.56% -95.98% 154.55% -34.33% 210.74% -158.34%
Operating Cash Flow Growth
11.95% 6.22% 13.21% 4.85% -10.36% -0.31% 0.20% -30.23% -0.66% -2.12%
Free Cash Flow Firm Growth
-1,947.45% 171.89% -160.44% 147.04% -101.55% -136.11% -17.27% -70.77% 23,686.22% 102.89%
Invested Capital Growth
28.78% 0.11% 3.53% -2.41% 7.70% 4.88% -10.35% -10.94% -27.31% 0.47%
Revenue Q/Q Growth
5.52% 1.32% 1.53% 4.14% 84.44% 15.31% -45.70% -4.07% 42.21% 6.07%
EBITDA Q/Q Growth
6.58% 6.78% -1.67% 7.31% -19.01% 45.38% -5.75% -20.04% -2.68% 445.54%
EBIT Q/Q Growth
-43.95% 26.48% -7.10% 25.11% -821.84% 168.54% -44.10% -65.49% -10.10% 129.40%
NOPAT Q/Q Growth
-43.75% 31.12% -7.29% 23.31% -851.75% 170.60% -44.47% -66.10% -11.65% 145.02%
Net Income Q/Q Growth
-19.49% 23.91% -4.05% -18.28% 31.62% -92.91% 492.53% -22.00% 4,101.79% -320.48%
EPS Q/Q Growth
-23.40% 27.27% -4.17% -18.42% 30.51% -94.67% 522.22% -22.12% 2,014.29% -320.48%
Operating Cash Flow Q/Q Growth
5.13% 2.61% -1.85% 0.66% 0.16% 0.20% 0.79% -0.74% -10.27% -0.90%
Free Cash Flow Firm Q/Q Growth
2.69% 9.71% 54.64% -52.84% -59.58% 34.25% 50.77% -76.60% 328.45% 101.53%
Invested Capital Q/Q Growth
-0.18% 0.76% 0.50% 3.41% -1.02% -3.46% -2.88% 1.16% -26.18% -3.66%
Profitability Metrics
- - - - - - - - - -
EBITDA Margin
41.39% 44.15% 41.86% 43.52% 39.32% 72.41% 64.52% 40.62% 50.33% 44.13%
EBIT Margin
1.45% 11.19% 9.10% 9.05% -4.52% 6.81% 4.08% 4.97% 14.71% 7.78%
Profit (Net Income) Margin
11.05% 16.90% 27.35% 30.26% 30.02% 5.87% 115.42% 27.43% 38.44% -37.40%
Tax Burden Percent
97.85% 106.29% 101.83% 409.71% 196.73% 34.06% 128.01% 102.98% 174.23% -400.98%
Interest Burden Percent
777.64% 142.08% 295.21% 81.59% -337.81% 253.13% 2,209.92% 536.01% 149.94% 119.87%
Effective Tax Rate
1.59% -3.05% -0.87% -2.54% -4.33% -3.11% -0.52% -0.32% 1.22% -7.20%
Return on Invested Capital (ROIC)
0.22% 1.66% 1.28% 1.20% -0.51% 0.58% 0.30% 0.54% 1.35% 0.59%
ROIC Less NNEP Spread (ROIC-NNEP)
3.20% 3.25% 6.70% 7.05% 7.55% 0.38% 15.70% 4.59% 5.28% -5.84%
Return on Net Nonoperating Assets (RNNOA)
3.13% 3.05% 5.88% 6.06% 6.62% 0.33% 17.43% 6.79% 6.81% -5.86%
Return on Equity (ROE)
3.34% 4.71% 7.16% 7.26% 6.11% 0.91% 17.73% 7.33% 8.16% -5.27%
Cash Return on Invested Capital (CROIC)
-24.94% 1.55% -2.19% 3.64% -7.93% -4.18% 11.22% 12.11% 32.97% 0.12%
Operating Return on Assets (OROA)
0.20% 1.41% 1.11% 1.01% -0.43% 0.52% 0.28% 0.51% 1.32% 0.53%
Return on Assets (ROA)
1.50% 2.13% 3.33% 3.37% 2.86% 0.45% 8.01% 2.83% 3.44% -2.55%
Return on Common Equity (ROCE)
3.09% 4.31% 6.53% 6.63% 5.59% 0.83% 16.47% 6.89% 7.74% -5.10%
Return on Equity Simple (ROE_SIMPLE)
3.18% 5.27% 7.76% 8.07% 6.36% 0.99% 18.06% 7.97% 11.54% -5.85%
Net Operating Profit after Tax (NOPAT)
35 228 173 161 -67 72 38 77 242 122
NOPAT Margin
1.43% 11.53% 9.18% 9.28% -4.71% 7.02% 4.10% 4.99% 14.53% 8.34%
Net Nonoperating Expense Percent (NNEP)
-2.99% -1.59% -5.42% -5.85% -8.06% 0.20% -15.40% -4.05% -3.93% 6.43%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
98.55% 88.81% 90.90% 90.95% 104.52% 93.19% 95.92% 95.03% 85.29% 92.22%
Earnings before Interest and Taxes (EBIT)
35 222 172 157 -64 70 38 77 245 114
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,002 874 790 756 561 741 600 626 838 645
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.66 1.58 1.77 2.51 1.96 2.16 1.62 1.60 1.80 1.18
Price to Tangible Book Value (P/TBV)
1.84 1.66 1.89 2.72 2.12 2.25 1.71 1.73 1.98 1.26
Price to Revenue (P/Rev)
5.77 5.07 6.25 9.39 9.24 12.83 10.37 5.50 6.01 7.55
Price to Earnings (P/E)
57.60 32.99 23.70 32.50 32.05 298.30 9.11 20.51 15.98 0.00
Dividend Yield
6.01% 6.54% 5.47% 3.96% 6.05% 5.58% 7.21% 8.20% 9.96% 9.53%
Earnings Yield
1.74% 3.03% 4.22% 3.08% 3.12% 0.34% 10.97% 4.88% 6.26% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.30 1.25 1.36 1.72 1.46 1.55 1.29 1.23 1.29 1.06
Enterprise Value to Revenue (EV/Rev)
9.57 8.74 9.96 13.18 14.00 19.18 16.82 10.75 11.69 15.14
Enterprise Value to EBITDA (EV/EBITDA)
23.11 19.80 23.79 30.29 35.61 26.48 26.07 26.46 23.22 34.30
Enterprise Value to EBIT (EV/EBIT)
659.00 78.13 109.45 145.64 0.00 281.56 412.22 216.31 79.43 194.53
Enterprise Value to NOPAT (EV/NOPAT)
669.66 75.82 108.50 142.03 0.00 273.08 410.07 215.61 80.41 181.47
Enterprise Value to Operating Cash Flow (EV/OCF)
21.62 18.11 20.89 28.81 26.34 23.18 18.43 19.55 16.03 18.10
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 81.25 0.00 46.71 0.00 0.00 10.92 9.56 3.28 887.61
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.96 0.99 0.89 0.86 0.86 0.90 0.85 1.41 1.55 1.14
Long-Term Debt to Equity
0.95 0.89 0.75 0.70 0.86 0.89 0.84 1.39 1.53 1.13
Financial Leverage
0.98 0.94 0.88 0.86 0.88 0.88 1.11 1.48 1.29 1.00
Leverage Ratio
2.23 2.21 2.15 2.15 2.14 2.03 2.21 2.59 2.37 2.06
Compound Leverage Factor
17.34 3.15 6.35 1.76 -7.22 5.14 48.93 13.87 3.56 2.47
Debt to Total Capital
49.04% 49.82% 47.13% 46.33% 46.15% 47.37% 46.09% 58.48% 60.73% 53.18%
Short-Term Debt to Total Capital
0.84% 5.22% 7.22% 8.76% 0.00% 0.73% 0.75% 0.70% 0.61% 0.45%
Long-Term Debt to Total Capital
48.20% 44.61% 39.91% 37.58% 46.15% 46.64% 45.34% 57.78% 60.12% 52.72%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.69% 4.16% 4.60% 4.74% 4.50% 4.60% 4.70% 2.18% 2.60% 1.93%
Common Equity to Total Capital
47.27% 46.01% 48.27% 48.93% 49.35% 48.03% 49.21% 39.34% 36.66% 44.89%
Debt to EBITDA
8.70 7.86 8.22 8.16 11.23 8.11 9.28 12.59 10.97 17.17
Net Debt to EBITDA
8.52 7.67 8.06 7.88 11.03 7.98 9.05 12.46 10.80 16.57
Long-Term Debt to EBITDA
8.55 7.04 6.96 6.61 11.23 7.98 9.13 12.44 10.86 17.02
Debt to NOPAT
252.14 30.10 37.50 38.24 -93.68 83.57 145.97 102.59 37.98 90.83
Net Debt to NOPAT
246.81 29.36 36.77 36.93 -92.02 82.27 142.30 101.52 37.41 87.66
Long-Term Debt to NOPAT
247.80 26.95 31.75 31.02 -93.68 82.28 143.59 101.36 37.60 90.05
Noncontrolling Interest Sharing Ratio
7.70% 8.50% 8.76% 8.59% 8.53% 8.73% 7.12% 5.96% 5.08% 3.20%
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-3,938 213 -297 491 -1,043 -517 1,433 1,732 5,926 25
Operating Cash Flow to CapEx
924.56% 841.79% 829.66% 713.35% 805.80% 777.33% 799.21% 734.90% 0.00% 10,977.68%
Free Cash Flow to Firm to Interest Expense
-14.04 1.06 -1.71 3.11 -4.78 -2.38 5.48 5.63 12.76 0.05
Operating Cash Flow to Interest Expense
3.82 4.77 5.21 5.03 3.47 3.89 3.25 2.75 2.61 2.55
Operating Cash Flow Less CapEx to Interest Expense
3.40 4.21 4.58 4.33 3.04 3.39 2.84 2.38 3.81 2.53
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.14 0.13 0.12 0.11 0.10 0.08 0.07 0.10 0.09 0.07
Fixed Asset Turnover
0.17 0.15 0.15 0.15 0.15 0.11 0.09 0.14 0.14 0.13
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
17,774 13,801 13,786 13,316 13,645 12,670 12,080 13,475 15,131 20,815
Invested Capital Turnover
0.15 0.14 0.14 0.13 0.11 0.08 0.07 0.11 0.09 0.07
Increase / (Decrease) in Invested Capital
3,973 15 470 -329 976 589 -1,395 -1,655 -5,685 97
Enterprise Value (EV)
23,149 17,319 18,802 22,914 19,976 19,612 15,642 16,562 19,456 22,115
Market Capitalization
13,961 10,037 11,798 16,325 13,176 13,121 9,646 8,470 10,010 11,030
Book Value per Share
$12.01 $11.61 $12.38 $12.09 $12.51 $12.29 $12.65 $11.30 $11.85 $20.09
Tangible Book Value per Share
$10.84 $11.03 $11.60 $11.12 $11.54 $11.77 $12.00 $10.43 $10.83 $18.83
Total Capital
17,774 13,801 13,786 13,316 13,645 12,670 12,080 13,475 15,131 20,815
Total Debt
8,716 6,876 6,498 6,170 6,298 6,002 5,568 7,880 9,189 11,069
Total Long-Term Debt
8,566 6,156 5,502 5,004 6,298 5,909 5,477 7,786 9,097 10,975
Net Debt
8,532 6,707 6,371 5,958 6,187 5,908 5,428 7,798 9,053 10,682
Capital Expenditures (CapEx)
116 114 109 111 94 109 106 115 -556 11
Net Nonoperating Expense (NNE)
-233 -106 -343 -365 -495 12 -1,035 -346 -398 668
Net Nonoperating Obligations (NNO)
8,716 6,876 6,498 6,170 6,298 6,002 5,568 7,880 9,189 11,069
Total Depreciation and Amortization (D&A)
966 653 619 599 625 671 562 549 593 531
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.36 $0.56 $0.92 $0.93 $0.77 $0.09 $2.25 $0.88 $1.34 ($1.11)
Adjusted Weighted Average Basic Shares Outstanding
675.68M 547.01M 538.81M 538.93M 530.56M 486.26M 470.55M 468.76M 467.20M 506.09M
Adjusted Diluted Earnings per Share
$0.36 $0.56 $0.92 $0.93 $0.77 $0.09 $2.24 $0.88 $1.34 ($1.11)
Adjusted Weighted Average Diluted Shares Outstanding
676.23M 547.28M 539.15M 539.24M 531.06M 489.34M 475.39M 468.94M 467.40M 506.09M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.09 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
699.56M 547.17M 546.78M 539.30M 538.69M 505.41M 477.77M 469.44M 468.18M 509.08M
Normalized Net Operating Profit after Tax (NOPAT)
188 164 129 128 -2.23 63 35 176 252 175
Normalized NOPAT Margin
7.76% 8.26% 6.81% 7.34% -0.16% 6.11% 3.76% 11.40% 15.12% 11.95%
Pre Tax Income Margin
11.29% 15.90% 26.86% 7.39% 15.26% 17.24% 90.17% 26.64% 22.06% 9.33%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.13 1.11 0.99 1.00 -0.30 0.32 0.15 0.25 0.53 0.24
NOPAT to Interest Expense
0.12 1.14 1.00 1.02 -0.31 0.33 0.15 0.25 0.52 0.25
EBIT Less CapEx to Interest Expense
-0.29 0.54 0.37 0.29 -0.73 -0.18 -0.26 -0.13 1.73 0.21
NOPAT Less CapEx to Interest Expense
-0.29 0.57 0.37 0.32 -0.74 -0.17 -0.26 -0.12 1.72 0.23
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
297.33% 196.27% 125.49% 123.61% 183.79% 1,198.99% 64.92% 164.43% 153.07% -191.55%
Augmented Payout Ratio
368.67% 198.22% 138.62% 126.05% 186.25% 1,207.38% 65.24% 165.57% 154.43% -193.14%

Quarterly Metrics And Ratios for Healthpeak Properties

This table displays calculated financial ratios and metrics derived from Healthpeak Properties' official financial filings.

Metric Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period end date 10/31/2024 7/31/2024 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Growth Metrics
- - - - - - - - - - -
Revenue Growth
18.66% 15.28% 15.49% 25.28% 23.84% 25.03% 14.22% 5.43% 6.17% 4.26% 3.67%
EBITDA Growth
48.86% 47.41% 123.25% 27.92% 28.67% 32.68% -34.52% 33.49% 10.99% 2.92% -0.12%
EBIT Growth
46.80% 47.33% 201.93% -47.99% -46.55% -38.57% -217.04% 422.20% 21.41% -13.15% -1.75%
NOPAT Growth
46.23% 47.58% 350.60% -69.59% -46.98% -38.36% -145.89% 484.97% 18.71% -15.85% -0.93%
Net Income Growth
67.05% 60.10% 347.92% -85.85% 35.08% 171.74% -91.69% 597.97% -80.82% -22.26% 78.53%
EPS Growth
70.00% 61.76% 500.00% -84.62% 0.00% 133.33% -95.45% 1,200.00% -81.54% -30.77% 69.23%
Operating Cash Flow Growth
340.88% 74.54% 83.16% 22.61% 25.64% 6.17% -12.28% 11.74% 3.95% 16.57% -10.43%
Free Cash Flow Firm Growth
109.12% 76.50% 114.75% -7,493.81% -4,882.92% -1,709.83% -1,812.59% 111.67% 110.84% 73.08% 1.86%
Invested Capital Growth
-38.81% -27.29% -3.46% 28.78% 29.99% 31.60% 34.20% 0.11% -0.15% 2.12% 2.21%
Revenue Q/Q Growth
5.00% 2.84% 0.43% 0.19% 0.92% 13.73% 8.94% -0.96% 1.89% 3.90% 0.56%
EBITDA Q/Q Growth
32.76% 35.70% 6.84% -3.05% 0.50% 114.45% -38.78% -2.48% 3.63% 5.83% 24.81%
EBIT Q/Q Growth
31.62% 35.64% 102.39% -15.20% 19.96% 149.51% -203.27% -12.85% 37.88% -5.68% 360.77%
NOPAT Q/Q Growth
30.99% 36.06% 178.05% -39.45% 19.70% 224.34% -133.74% 5.58% 39.17% -7.43% 330.09%
Net Income Q/Q Growth
50.85% 48.24% 369.12% -88.49% -39.27% 1,266.34% -85.18% 9.82% 22.17% -58.22% 1,145.20%
EPS Q/Q Growth
53.85% 50.00% 200.00% -83.33% -42.86% 2,000.00% -92.31% 8.33% 33.33% -59.09% 2,100.00%
Operating Cash Flow Q/Q Growth
545.25% -130.45% -1.45% -10.90% 0.63% 107.26% -34.03% -8.69% -14.96% 71.24% -15.96%
Free Cash Flow Firm Q/Q Growth
127.49% 69.26% 117.55% 3.00% 5.24% 8.56% -8,895.93% -37.25% 135.86% 3.37% 46.34%
Invested Capital Q/Q Growth
-17.75% 21.71% -0.30% -0.18% -1.20% -1.82% 33.00% 0.76% 0.02% 0.12% -0.79%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
82.82% 81.71% - - - - - - - - -
EBITDA Margin
-16.98% -26.52% 48.02% 45.14% 46.64% 46.84% 24.84% 44.20% 44.89% 44.14% 43.33%
Operating Margin
-17.23% -26.22% - - - - - - - - -
EBIT Margin
-17.18% -26.38% 9.59% 4.76% 5.62% 4.73% -10.86% 11.46% 13.02% 9.62% 10.60%
Profit (Net Income) Margin
-7.50% -16.02% 7.94% 1.70% 14.81% 24.61% 2.05% 15.05% 13.58% 11.32% 28.16%
Tax Burden Percent
104.93% 102.52% 92.21% -329.99% 94.14% 98.28% 49.68% 125.67% 101.95% 102.92% 101.14%
Interest Burden Percent
41.62% 59.26% 89.86% -10.83% 279.83% 529.54% -37.96% 104.53% 102.25% 114.32% 262.61%
Effective Tax Rate
0.00% 0.00% 3.83% 0.00% 1.97% 1.76% 60.88% -19.74% 1.17% 2.08% 0.23%
Return on Invested Capital (ROIC)
0.00% 0.00% 1.28% 0.51% 0.80% 0.64% -0.54% 1.97% 1.84% 1.34% 1.49%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 1.19% 0.38% 1.57% 2.27% -0.09% 2.07% 1.89% 1.48% 2.80%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 1.14% 0.37% 1.47% 2.08% -0.08% 1.95% 1.77% 1.37% 2.51%
Return on Equity (ROE)
-9.98% -12.29% 2.42% 0.88% 2.27% 2.72% -0.63% 3.92% 3.60% 2.71% 4.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 4.40% -24.94% -25.69% -26.71% -28.52% 1.55% 1.42% -0.88% -0.92%
Operating Return on Assets (OROA)
-6.86% -10.13% 1.19% 0.65% 0.72% 0.57% -1.23% 1.44% 1.63% 1.20% 1.31%
Return on Assets (ROA)
-3.00% -6.15% 0.99% 0.23% 1.91% 2.99% 0.23% 1.89% 1.70% 1.41% 3.47%
Return on Common Equity (ROCE)
-9.98% -12.29% 2.24% 0.81% 2.10% 2.51% -0.58% 3.59% 3.29% 2.47% 3.65%
Return on Equity Simple (ROE_SIMPLE)
-9.72% -12.05% 3.74% 0.00% 3.88% 3.52% 2.38% 0.00% 4.18% 8.56% 8.71%
Net Operating Profit after Tax (NOPAT)
-21 -30 58 21 35 29 -23 69 65 47 51
NOPAT Margin
-12.06% -18.35% 9.22% 3.33% 5.51% 4.65% -4.25% 13.72% 12.87% 9.42% 10.58%
Net Nonoperating Expense Percent (NNEP)
0.61% 0.30% 0.09% 0.13% -0.76% -1.63% -0.45% -0.10% -0.05% -0.14% -1.31%
Cost of Revenue to Revenue
17.18% 18.29% - - - - - - - - -
SG&A Expenses to Revenue
19.43% 21.57% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
30.78% 33.29% - - - - - - - - -
Operating Expenses to Revenue
100.05% 107.93% 90.41% 95.24% 94.38% 95.27% 110.86% 88.54% 86.98% 90.38% 89.40%
Earnings before Interest and Taxes (EBIT)
-30 -44 60 30 35 29 -59 57 66 48 51
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-29 -44 303 283 292 291 136 221 227 219 207
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.46 5.50 1.72 1.66 1.81 1.51 1.09 1.58 1.42 1.51 1.61
Price to Tangible Book Value (P/TBV)
5.56 5.60 1.89 1.84 2.03 1.72 1.25 1.66 1.49 1.60 1.71
Price to Revenue (P/Rev)
10.49 10.81 5.62 5.77 6.77 6.08 4.72 5.07 4.68 5.13 5.58
Price to Earnings (P/E)
0.00 0.00 50.55 57.60 50.31 46.01 50.09 32.99 38.07 18.64 19.48
Dividend Yield
0.00% 0.00% 5.99% 6.01% 5.40% 6.39% 6.79% 6.54% 7.18% 6.65% 6.17%
Earnings Yield
0.00% 0.00% 1.98% 1.74% 1.99% 2.17% 2.00% 3.03% 2.63% 5.36% 5.13%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 1.32 1.30 1.38 1.24 1.03 1.25 1.19 1.23 1.29
Enterprise Value to Revenue (EV/Rev)
8.43 8.72 9.37 9.57 10.70 10.27 9.27 8.74 8.32 8.76 9.23
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 20.08 23.11 26.11 25.51 23.64 19.80 19.87 21.18 22.25
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 151.54 659.00 391.47 239.11 169.91 78.13 92.84 103.09 102.90
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 148.01 669.66 399.21 243.40 173.11 75.82 93.39 102.52 102.02
Enterprise Value to Operating Cash Flow (EV/OCF)
81.19 142.16 19.59 21.62 24.10 23.41 20.31 18.11 17.46 18.29 19.98
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 29.56 0.00 0.00 0.00 0.00 81.25 83.74 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 1.00 0.96 0.93 0.91 0.91 0.99 0.95 0.92 0.89
Long-Term Debt to Equity
0.00 0.00 0.99 0.95 0.93 0.91 0.89 0.89 0.89 0.88 0.82
Financial Leverage
-1.06 -1.06 0.96 0.98 0.94 0.92 0.90 0.94 0.94 0.92 0.90
Leverage Ratio
1.34 1.35 2.19 2.23 2.19 2.16 2.15 2.21 2.21 2.20 2.16
Compound Leverage Factor
0.56 0.80 1.97 -0.24 6.12 11.45 -0.82 2.31 2.26 2.51 5.68
Debt to Total Capital
0.00% 0.00% 50.09% 49.04% 48.21% 47.74% 47.70% 49.82% 48.66% 47.97% 47.19%
Short-Term Debt to Total Capital
0.00% 0.00% 0.93% 0.84% 0.00% 0.14% 1.00% 5.22% 3.10% 2.40% 4.07%
Long-Term Debt to Total Capital
0.00% 0.00% 49.17% 48.20% 48.21% 47.60% 46.70% 44.61% 45.56% 45.56% 43.12%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 3.70% 3.69% 3.70% 3.67% 3.91% 4.16% 4.20% 4.31% 4.49%
Common Equity to Total Capital
100.00% 100.00% 46.21% 47.27% 48.09% 48.59% 48.39% 46.01% 47.14% 47.72% 48.33%
Debt to EBITDA
0.00 0.00 7.60 8.70 9.13 9.84 10.90 7.86 8.14 8.25 8.17
Net Debt to EBITDA
0.00 0.00 7.48 8.52 8.88 9.65 10.71 7.67 8.00 8.05 8.02
Long-Term Debt to EBITDA
0.00 0.00 7.46 8.55 9.13 9.81 10.68 7.04 7.62 7.83 7.46
Debt to NOPAT
0.00 0.00 56.00 252.14 139.67 93.83 79.83 30.10 38.25 39.92 37.44
Net Debt to NOPAT
0.00 0.00 55.13 246.81 135.73 92.09 78.39 29.36 37.60 38.94 36.76
Long-Term Debt to NOPAT
0.00 0.00 54.97 247.80 139.67 93.56 78.16 26.95 35.82 37.92 34.22
Altman Z-Score
9.73 9.37 - - - - - - - - -
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 7.45% 7.70% 7.60% 7.57% 7.92% 8.50% 8.72% 8.82% 8.77%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.79 3.71 - - - - - - - - -
Quick Ratio
3.60 3.52 - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3.89 -14 693 -3,952 -4,074 -4,299 -4,701 53 85 -238 -246
Operating Cash Flow to CapEx
1,562.94% -325.81% 1,207.77% 726.26% 1,353.53% 885.27% 870.95% 488.57% 1,053.88% 1,531.66% 763.18%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 9.54 -56.04 -54.97 -57.38 -77.18 1.01 1.69 -4.84 -5.12
Operating Cash Flow to Interest Expense
0.00 0.00 3.84 4.02 4.29 4.22 2.50 4.38 5.01 6.07 3.63
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 3.53 3.47 3.98 3.74 2.22 3.48 4.54 5.67 3.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.40 0.38 0.12 0.14 0.13 0.12 0.11 0.13 0.13 0.12 0.12
Accounts Receivable Turnover
5.51 4.65 - - - - - - - - -
Inventory Turnover
0.00 0.00 - - - - - - - - -
Fixed Asset Turnover
0.00 0.00 0.15 0.17 0.16 0.15 0.14 0.15 0.15 0.15 0.15
Accounts Payable Turnover
8.64 10.99 - - - - - - - - -
Days Sales Outstanding (DSO)
66.19 78.55 - - - - - - - - -
Days Inventory Outstanding (DIO)
0.00 0.00 - - - - - - - - -
Days Payable Outstanding (DPO)
42.27 33.20 - - - - - - - - -
Cash Conversion Cycle (CCC)
23.93 45.35 - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-89 -75 17,720 17,774 17,805 18,022 18,355 13,801 13,697 13,694 13,678
Invested Capital Turnover
-8.58 -9.33 0.14 0.15 0.15 0.14 0.13 0.14 0.14 0.14 0.14
Increase / (Decrease) in Invested Capital
-25 -16 -635 3,973 4,108 4,327 4,678 15 -20 284 296
Enterprise Value (EV)
5,524 5,476 23,461 23,149 24,534 22,316 18,987 17,319 16,271 16,870 17,584
Market Capitalization
6,870 6,785 14,068 13,961 15,534 13,211 9,671 10,037 9,145 9,871 10,634
Book Value per Share
$6.20 $6.14 $11.70 $12.01 $12.25 $12.44 $14.78 $11.61 $11.80 $11.95 $12.09
Tangible Book Value per Share
$6.09 $6.03 $10.64 $10.84 $10.96 $10.91 $12.85 $11.03 $11.18 $11.28 $11.37
Total Capital
1,258 1,234 17,720 17,774 17,805 18,022 18,355 13,801 13,697 13,694 13,678
Total Debt
0.00 0.00 8,877 8,716 8,583 8,603 8,756 6,876 6,664 6,569 6,454
Total Long-Term Debt
0.00 0.00 8,713 8,566 8,583 8,578 8,573 6,156 6,240 6,240 5,898
Net Debt
-1,346 -1,309 8,738 8,532 8,341 8,444 8,599 6,707 6,550 6,408 6,337
Capital Expenditures (CapEx)
2.44 2.63 23 39 24 36 18 47 24 19 23
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-204 -188 - - - - - - - - -
Debt-free Net Working Capital (DFNWC)
1,143 1,122 - - - - - - - - -
Net Working Capital (NWC)
1,143 1,122 - - - - - - - - -
Net Nonoperating Expense (NNE)
-7.91 -3.85 8.04 10 -58 -124 -34 -6.67 -3.56 -9.43 -84
Net Nonoperating Obligations (NNO)
-1,346 -1,309 8,877 8,716 8,583 8,603 8,756 6,876 6,664 6,569 6,454
Total Depreciation and Amortization (D&A)
0.34 -0.23 242 253 257 261 195 164 161 171 156
Debt-free, Cash-free Net Working Capital to Revenue
-31.10% -29.90% - - - - - - - - -
Debt-free Net Working Capital to Revenue
174.49% 178.71% - - - - - - - - -
Net Working Capital to Revenue
174.49% 178.71% - - - - - - - - -
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.06) ($0.13) $0.06 $0.02 $0.12 $0.21 $0.01 $0.13 $0.12 $0.09 $0.22
Adjusted Weighted Average Basic Shares Outstanding
203.53M 201.87M 699.07M 675.68M 699.35M 702.38M 600.90M 547.01M 547.06M 547.03M 546.84M
Adjusted Diluted Earnings per Share
($0.06) ($0.13) $0.06 $0.02 $0.12 $0.21 $0.01 $0.13 $0.12 $0.09 $0.22
Adjusted Weighted Average Diluted Shares Outstanding
203.53M 201.87M 699.12M 676.23M 700.15M 703.27M 601.19M 547.28M 547.33M 547.29M 547.11M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
204.45M 202.89M 694.73M 699.56M 699.44M 699.29M 703.78M 547.17M 547.07M 547.05M 547.00M
Normalized Net Operating Profit after Tax (NOPAT)
-21 -30 60 36 42 36 42 46 65 50 51
Normalized NOPAT Margin
-12.06% -18.35% 9.52% 5.81% 6.70% 5.79% 7.62% 9.28% 12.77% 10.06% 10.62%
Pre Tax Income Margin
-7.15% -15.63% 8.61% -0.52% 15.73% 25.04% 4.12% 11.98% 13.32% 11.00% 27.84%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.83 0.42 0.48 0.39 -0.97 1.09 1.30 0.97 1.06
NOPAT to Interest Expense
0.00 0.00 0.80 0.30 0.47 0.38 -0.38 1.30 1.29 0.95 1.05
EBIT Less CapEx to Interest Expense
0.00 0.00 0.51 -0.13 0.16 -0.09 -1.26 0.19 0.83 0.58 0.58
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.48 -0.26 0.15 -0.09 -0.67 0.41 0.81 0.56 0.58
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 275.67% 297.33% 225.60% 228.36% 310.39% 196.27% 242.08% 116.48% 112.85%
Augmented Payout Ratio
0.00% 0.00% 312.78% 368.67% 282.94% 283.66% 358.66% 198.22% 244.56% 127.69% 123.79%

Frequently Asked Questions About Healthpeak Properties' Financials

When does Healthpeak Properties's fiscal year end?

According to the most recent income statement we have on file, Healthpeak Properties' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Healthpeak Properties' net income changed over the last 9 years?

Healthpeak Properties' net income appears to be on an upward trend, with a most recent value of $267.30 million in 2024, falling from -$546.42 million in 2015. The previous period was $334.76 million in 2023. Find out what analysts predict for Healthpeak Properties in the coming months.

How has Healthpeak Properties revenue changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' total revenue changed from $1.46 billion in 2015 to $2.42 billion in 2024, a change of 65.7%.

How much debt does Healthpeak Properties have?

Healthpeak Properties' total liabilities were at $10.88 billion at the end of 2024, a 24.0% increase from 2023, and a 7.0% decrease since 2015.

How much cash does Healthpeak Properties have?

In the past 9 years, Healthpeak Properties' cash and equivalents has ranged from $44.23 million in 2020 to $340.44 million in 2015, and is currently $119.82 million as of their latest financial filing in 2024.

How has Healthpeak Properties' book value per share changed over the last 9 years?

Over the last 9 years, Healthpeak Properties' book value per share changed from 20.09 in 2015 to 12.01 in 2024, a change of -40.2%.



This page (NYSE:DOC) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners